Exercise therapy in Type 2 diabetes

Overview of attention for article published in Acta Diabetologica, May 2009

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)

Mentioned by

policy: 1 policy source
twitter: 1 X user

facebook: 2 Facebook pages

Citations

dimensions_citation: 93 Dimensions

Readers on

mendeley: 234 Mendeley
citeulike: 2 CiteULike

Summary Policy documents X Facebook Dimensions citations

So far, Altmetric has seen 2 policy documents that reference this research output.

Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes: Committee papers

Cited by National Institute for Health and Care Excellence on 23 Dec 2015

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes: Assessment report

Cited by National Institute for Health and Care Excellence on 19 Oct 2015

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.